Altering eligibility criteria and requirements for claiming a credit against the State income tax for investments in specified biotechnology businesses; prohibiting the certification of credits for investments in a single company for any fiscal year in excess of 15% of the total appropriations to the Reserve Fund for the fiscal year; providing that the credit may be claimed over 2 taxable years, beginning with the second year after the taxable year in which the investment was made; etc.